Pre-treatment neutrophil to lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival outcomes in metastatic advanced gastric cancer

被引：0
|
作者：
In Rae Cho
Jun Chul Park
Chan Hyuk Park
Jung Hyun Jo
Hyun Jik Lee
Sunyong Kim
Choong Nam Shim
Hyuk Lee
Sung Kwan Shin
Sang Kil Lee
Yong Chan Lee
机构：
[1] Yonsei University College of Medicine,Department of Internal Medicine and Institute of Gastroenterology, Severance Hospital
来源：
Gastric Cancer | 2014年 / 17卷
关键词：
Gastric cancer; Chemotherapy; Survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：703 / 710
页数：7
相关论文
共 50 条
  • [21] Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment
    HanByoul Cho
    Hye Won Hur
    Sang Wun Kim
    Sung Hoon Kim
    Jae Hoon Kim
    Young Tae Kim
    Kook Lee
    Cancer Immunology, Immunotherapy, 2009, 58 : 15 - 23
  • [22] Baseline blood neutrophil-lymphocyte ratio to predict treatment response in gastric cancer
    Diaz Romero, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [23] Neutrophil-to-lymphocyte ratio as a prognostic marker for metastatic pancreatic cancer.
    Desai, Jasmin Radhika
    Colton, Bradley Scott
    Wang, Hongkun
    Marshall, John
    Kim, Sunnie S.
    Pishvaian, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [24] Validation of the pre-treatment neutrophil-to-lymphocyte ratio to predict response to corticosteroids in severe alcoholic hepatitis
    Forrest, Ewan
    Dhanda, Ashwin
    Katarey, Dev
    Potts, Jonathan
    Verma, Sumita
    Parker, Richard
    Hayes, Peter
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E277 - E277
  • [25] Pre-Treatment and Post-Treatment Neutrophil-to-Lymphocyte Ratio Predict Pathological Tumor Response and Survival in Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy
    Delikgoz Soykut, Ela
    Kemal, Yasemin
    Odabasi, Eylem
    Sahin, Nilgun
    Keskinkilic Yagiz, Betul
    Yazicioglu, Irem Melike
    Aytac Arslan, Suheyla
    Guney, Vildiz
    TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2022, 37 (02): : 139 - 149
  • [26] Pre-treatment neutrophil lymphocyte ratio/platelet lymphocyte ratio as surrogate markers of survival in non-metastatic head and neck cancer patients: An observational study
    Agarwal, V.
    Rao, R.
    Abin, H. R.
    Rao, V.
    Nayar, R. C.
    Mani, V.
    Ram, A.
    Ajaikumar, B. S.
    ANNALS OF ONCOLOGY, 2017, 28
  • [27] Pre-treatment Neutrophil to Lymphocyte Ratio Is a Predictor of Prognosis in Endometrial Cancer
    Haruma, Tomoko
    Nakamura, Keiichiro
    Nishida, Takeshi
    Ogawa, Chikako
    Kusumoto, Tomoyuki
    Seki, Noriko
    Hiramatsu, Yuji
    ANTICANCER RESEARCH, 2015, 35 (01) : 337 - 343
  • [28] Prognostic value of pre-treatment neutrophil to lymphocyte ratio in metastatic renal cell carcinoma: a meta-analysis
    Dhani, Fauzan Kurniawan
    Budaya, Taufiq Nur
    Yahya, Hasan
    INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 : 52 - 52
  • [29] Pre-treatment Neutrophil to Lymphocyte Ratio predicts Overall Survival in Prostate Brachytherapy
    Garcia, S.
    Fernandes, P.
    Trigo, L.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S538 - S538
  • [30] The utilization of pre-treatment neutrophil to lymphocyte ratio as a predictive marker for response to nivolumab therapy in non small cell lung cancer
    Preeshagul, Isabel Ruth
    Sullivan, Kevin M.
    Paul, Doru
    Seetharamu, Nagashree
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345